Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
KABE Group B | KABEB | Nov 25, 2024 | 300.00 | 0.00 |
Kakel Max | KAKEL | Nov 25, 2024 | 9.95 | 0.00 |
Kallebäck Property Invest | KAPIAB | Nov 25, 2024 | 176.50 | -0.56 |
Kambi Group | KAMBI | Nov 25, 2024 | 107.90 | +0.19 |
Kancera | KAN | Nov 25, 2024 | 1.10 | +3.20 |
Karnell Group AB (publ) | KARNELB | Nov 25, 2024 | 44.39 | +1.46 |
Karnov Group | KAR | Nov 25, 2024 | 80.90 | +0.37 |
Karolinska Development B | KDEV | Nov 25, 2024 | 1.03 | -0.77 |
Katalysen Ventures AB | KAV | Nov 25, 2024 | 13.90 | +15.83 |
KebNi B | KEBNIB | Nov 25, 2024 | 0.94 | -0.11 |
Kentima Holding B | KENH | Nov 25, 2024 | 2.20 | +4.76 |
Kiliaro | KILI | Nov 25, 2024 | 0.27 | +11.34 |
Kinda Brave | BRAVE | Nov 25, 2024 | 1.43 | -8.92 |
Kindred Group SDB | KINDSDB | Nov 25, 2024 | 129.10 | 0.00 |
Kinnevik A | KINVA | Nov 25, 2024 | 77.40 | +1.95 |
Kinnevik B | KINVB | Nov 25, 2024 | 76.85 | +2.00 |
Kjell Group | KJELL | Nov 25, 2024 | 11.20 | -3.03 |
KlaraBo | KLARAB | Nov 25, 2024 | 19.68 | -1.01 |
Klaria Pharma Holding | KLAR | Nov 25, 2024 | 0.50 | +25.94 |
Klimator | KLIMAT | Nov 25, 2024 | 2.10 | 0.00 |
Knowit | KNOW | Nov 25, 2024 | 133.80 | +0.30 |
Kontigo Care | KONT | Nov 25, 2024 | 2.72 | +4.62 |
Kopparbergs B | KOBRB | Nov 25, 2024 | 112.00 | 0.00 |
Krona Public Real Estate | KRONA | Nov 25, 2024 | 48.40 | +0.41 |
Kvix | KVIX | Nov 25, 2024 | 0.50 | -3.85 |
Lagercrantz Group B | LAGRB | Nov 25, 2024 | 195.10 | +0.67 |
Lammhults Design Group B | LAMMB | Nov 25, 2024 | 23.10 | -0.86 |
Lappland Guldprospektering AB | LGOLDB | 0.00 | 0.00 | |
Latour B | LATOB | Nov 25, 2024 | 274.10 | +0.07 |
LC-Tec Holding | LCT | Nov 25, 2024 | 0.15 | +21.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.